Intercellular adhesionmolecule-1 and vascular cell adhesionmolecule-1

Endothelial Biomedicine

Volumn , Issue , 2007, Pages 1058-1070

  Muro, Silvia ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928854056     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511546198.118     Document Type: Chapter

References (139)

1. Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physi-ology and in the pathophysiology of vascular disorders. Blood. 1998;91(10):3527-3561.
2. Gimbrone MA Jr. Vascular endothelium, hemodynamic forces, and atherogenesis. Am JPathol. 1999;155(1):1-5.
3. Simionescu M, Gafencu A, Antohe F. Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. MicroscRes Tech. 2002;57(5):269-288.
4. Vanhoutte PM. Endothelium-derived free radicals: for worse and for better. J Clin Invest. 2001;107(1):23-25.
5. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993;11:767-804.
6. Zimmerman GA, Prescott SM, McIntyre TM. Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today. 1992;13(3):93-100.
7. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76 (2):301-314.
8. Worthylake RA, Burridge K. Leukocyte transendothelial migration: orchestrating the underlying molecular machinery. Curr Opin Cell Biol. 2001;13(5):569-577.
9. Dustin ML, Rothlein R, Bhan AK, et al. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and func-tion of a natural adherence molecule (ICAM-1). J Immunol. 1986;137(1):245-254.
10. Rothlein R, Dustin ML, Marlin SD, Springer TA. Ahuman inter-cellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol. 1986;137(4):1270-1274.
11. Rothlein R, Springer TA. The requirement for lymphocyte function-associated antigen 1 in homotypic leukocyte adhesion stimulatedbyphorbol ester. JExpMed. 1986;163(5):1132-1149.
12. Pober JS, Gimbrone MA Jr., Lapierre LA, et al. Overlapping pat-terns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. JImmunol. 1986; 137(6):1893-1896.
13. Simmons D, Makgoba MW, Seed B. ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature. 1988;331(6157):624-627.
14. Staunton DE, Marlin SD, Stratowa C, et al. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell. 1988; 52(6):925-933.
15. Tomassini JE, Graham D, DeWitt CM, et al. cDNA cloning reveals that the major group rhinovirus receptor on HeLa cells is intercellular adhesion molecule 1. ProcNatlAcad Sci USA. 1989; 86(13):4907-4911.
16. Greve JM, Davis G, Meyer AM, et al. The major human rhi-novirus receptor is ICAM-1. Cell. 1989;56(5):839-847.
17. Rice GE, Bevilacqua MP. An inducible EC surface glycoprotein mediates melanoma adhesion. Science. 1989;246(4935):1303-1306.
18. Rice GE, Munro JM, Bevilacqua MP. Inducible cell adhesion molecule 110 (INCAM-110) is an endothelial receptor for lym-phocytes. A CD11/CD18-independent adhesion mechanism. J Exp Med. 1990;171(4):1369-1374.
19. Osborn L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothe-lial protein that binds to lymphocytes. Cell. 1989;59(6):1203-1211.
20. Rice GE, Munro JM, Corless C, Bevilacqua MP. Vascular and nonvascular expression of INCAM-110. A target for mononu-clear leukocyte adhesion in normal and inflamed human tissues. Am J Pathol. 1991;138(2):385-393.
21. Springer TA. Adhesion receptors of the immune system. Nature. 1990;346(6283):425-434.
22. Hermand P, Huet M, Callebaut I, et al. Binding sites ofleukocyte beta 2 integrins (LFA-1, Mac-1) on the human ICAM-4/LW blood group protein. J Biol Chem. 2000;275(34):26002-26010.
23. Staunton DE, Dustin ML, Springer TA. Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature. 1989;339(6219):61-64.
24. Huang MT, Mason JC, Birdsey GM, et al. Endothelial intercellu-laradhesion molecule (ICAM)-2 regulates angiogenesis. Blood. 2005;106(5):1636-1643.
25. Fawcett J, Holness CL, Needham LA, et al. Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes. Nature. 1992;360(6403):481-484.
26. Bailly P, Hermand P, Callebaut I, et al. The LW blood group glycoprotein is homologous to intercellular adhesion molecules. ProcNatlAcad Sci USA. 1994;91(12):5306-5310.
27. Yoshihara Y, Oka S, Nemoto Y, et al. An ICAM-related neuronal glycoprotein, telencephalin, with brain segment-specific expression. Neuron. 1994;12(3):541-553.
28. Jimenez D, Roda P, Springer TA, Casasnovas JM. Contribution of N-linked glycans to the conformation and function of inter-cellular adhesion molecules (ICAMs). J Biol Chem. 2005 Feb 18;280(7):5854-5861. Epub 2004 Nov 15.
29. Ogawa T, Yorioka N, Ito T, et al. Ultrastructural localization of vascular cell adhesion molecule-1 in proliferative and crescentic glomerulonephritis. Virchows Arch. 1996;429(4-5):283-291.
30. Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell. 1991;65(6):961-971.
31. Kameda H, Morita I, Handa M, et al. Re-expression of functional P-selectin molecules on the endothelial cell surface by repeated stimulation with thrombin. BrJHaematol. 1997;97(2):348-355.
32. Almenar-Queralt A, Duperray A, Miles LA, et al. Apical topog-raphy and modulation of ICAM-1 expression on activated endothelium. Am J Pathol. 1995;147(5):1278-1288.
33. O'Brien KD, Allen MD, McDonald TO, et al. Vascular cell adhe-sion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 1993;92(2):945-951.
34. Rosen GD, Sanes JR, LaChance R, et al. Roles for the integrin VLA-4 and its counter receptor VCAM-1 in myogenesis. Cell. 1992;69(7):1107-1119.
35. Beauchamp JR, Abraham DJ, Bou-Gharios G, et al. Expression and function of heterotypic adhesion molecules during differ-entiation ofhuman skeletal muscle in culture. Am J Pathol. 1992; 140(2):387-401.
36. Constantin G, Piccio L, Bussini S, et al. Induction of adhesion molecules on human Schwann cells by proinflammatory cytokines, an immunofluorescence study. J Neurol Sci. 1999; 170(2):124-130.
37. Etienne-Manneville S, Chaverot N, Strosberg AD, Couraud PO. ICAM-1-coupled signaling pathways in astrocytes converge to cyclic & response element-binding protein phosphorylation and TNF-alpha secretion. J Immunol. 1999;163(2):668-674.
38. Raju R, Dalakas MC. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes. Brain. 2005;128(Pt 8):1887-1896.
39. Muro S, Muzykantov VR. Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules. Curr Pharm Des. 2005;11(18):2383-2401.
40. Remy M, Valli N, Brethes D, et al. In vitro and in situ intercellular adhesion molecule-1 (ICAM-1) expression by endothelial cells lining a polyester fabric. Biomaterials. 1999;20(3):241-251.
41. Sadeghi MM, Schechner JS, Krassilnikova S, et al. Vascular cell adhesion molecule-1-targeted detection of endothelial activation in human microvasculature. Transplant Proc. 2004; 36(5):1585-1591.
42. Norris P, Poston RN, Thomas DS, et al. The expression of endothelial leukocyte adhesion molecule-1 (ELAM-1), inter-cellular adhesion molecule-1 (ICAM-1), and vascular cell adhe-sion molecule-1 (VCAM-1) in experimental cutaneous inflam-mation: a comparison of ultraviolet B erythema and delayed hypersensitivity. J Invest Dermatol. 1991;96(5):763-770.
43. Pober J, Cotran RS. What can be learned from the expression of endothelial adhesion molecules in tissues? Lab Invest. 1991; 64(3):301-305.
44. Nishio K, Suzuki Y, Aoki T, et al. Differential contribution of various adhesion molecules to leukocyte kinetics in pulmonary microvessels of hyperoxia-exposed rat lungs. Am J Respir Crit CareMed. 1998;157(2):599-609.
45. Yamaguchi K, Nishio K, Sato N, et al. Leukocyte kinetics in the pulmonary microcirculation: observations using real-time con-focal luminescence microscopy coupled with high-speed video analysis. Lab Invest. 1997;76(6):809-822.
46. Muller WA. Leukocyte-EC interactions in the inflammatory response. Lab Invest. 2002;82(5):521-533.
47. Muller AM, Cronen C, Muller KM, Kirkpatrick CJ. Heteroge-neous expression of cell adhesion molecules by endothelial cells in ARDS. J Pathol. 2002;198(2):270-275.
48. Cybulsky MI, Fries JW, Williams AJ, et al. Gene structure, chro-mosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. Proc Natl Acad Sci USA. 1991; 88(17):7859-7863.
49. Osborn L, Vassallo C, Benjamin CD. Activated endothelium binds lymphocytes through a novel binding site in the alter-nately spliced domain of vascular cell adhesion molecule-1. J Exp Med. 1992;176(1):99-107.
50. D'Souza SE, Byers-Ward VJ, Gardiner EE, et al. Identification of an active sequence within the first immunoglobulin domain of intercellular cell adhesion molecule-1 (ICAM-1) that interacts with fibrinogen. J Biol Chem. 1996;271(39):24270-24277.
51. Hopkins AM, Baird AW, Nusrat A. ICAM-1: targeted docking for exogenous as well as endogenous ligands. Adv Drug Deliv Rev. 2004;56(6):763-778.
52. Chuluyan HE, Osborn L, Lobb R, Issekutz AC. Domains 1 and4 ofvascular cell adhesion molecule-1 (CD106) both support very late activation antigen-4 (CD49d/CD29)-dependent monocyte transendothelial migration. J Immunol. 1995;155(6):3135-3134.
53. Carlos TM, Schwartz BR, Kovach NL, et al. Vascular cell adhesion molecule-1 mediates lymphocyte adherence to cytokine-activated cultured human endothelial cells. Blood. 1990;76(5):965-970.
54. Wang J, Springer TA. Structural specializations ofimmunoglob-ulin superfamily members for adhesion to integrins and viruses. Immunol Rev. 1998;163:197-215.
55. Holland J, Owens T. Signaling through intercellular adhesion molecule 1 (ICAM-1) in a B cell lymphoma line. The activation of Lyn tyrosine kinase and the mitogen-activated protein kinase pathway. JBiol Chem. 1997;272(14):9108-9112.
56. Matheny HE, Deem TL, Cook-Mills JM. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via EC NADPH oxidase. J Immunol. 2000;164(12):6550-6559.
57. Wang Q, Doerschuk CM. Neutrophil-induced changes in the biomechanical properties of endothelial cells: roles of ICAM-1 and reactive oxygen species. J Immunol. 2000;164(12):6487-6494.
58. Gardiner EE, D'Souza SE. Sequences within fibrinogen and intercellular adhesion molecule-1 (ICAM-1) modulate signals required for mitogenesis. J Biol Chem. 1999;274(17):11930-11936.
59. Hubbard AK, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med. 2000;28(9):1379-1386.
60. Pluskota E, Chen Y, D'Souza SE. Src homology domain 2-containing tyrosine phosphatase 2 associates with intercellular adhesion molecule 1 to regulate cell survival. J Biol Chem. 2000; 275(39):30029-30036.
61. Cuvelier SL, Paul S, Shariat N, et al. Eosinophil adhesion under flow conditions activates mechanosensitive signaling pathways in human endothelial cells. J Exp Med. 2005;202(6):865-876.
62. Lazaar AL, Krymskaya VP, Das SK. VCAM-1 activates phos-phatidylinositol 3-kinase and induces p120Cbl phosphorylation in human airway smooth muscle cells. J Immunol. 2001; 166(1):155-161.
63. Greenwood J, Etienne-Manneville S, Adamson P, Couraud PO. Lymphocyte migration into the central nervous system: impli-cation of ICAM-1 signalling at the blood-brain barrier. Vascul Pharmacol. 2002;38(6):315-322.
64. Clayton A, Evans RA, Pettit E, et al. Cellular activation through the ligation of intercellular adhesion molecule-1. JCellSci. 1998; 111(Pt 4):443-453.
65. Alevriadou BR. CAMs and Rho small GTPases: gatekeepers for leukocyte transendothelial migration. Focus on –VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration.— Am J Physiol Cell Physiol. 2003;285(2):C250-C252.
66. Ricard I, Payet MD, Dupuis G. Clustering the adhesion molecules VLA-4 (CD49d/CD29) in Jurkat T cells or VCAM-1 (CD106) in endothelial (ECV 304) cells activates the phos-phoinositide pathway and triggers Ca2+ mobilization. Eur J Immunol. 1997;27(6):1530-1538.
67. Tudor KS, Hess KL, Cook-Mills JM. Cytokines modulate EC intracellular signal transduction required for VCAM-1-dependent lymphocyte transendothelial migration. Cytokine. 2001;15(4):196-211.
68. Etienne-Manneville S, Manneville JB, Adamson P, et al. ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J Immunol. 2000;165(6):3375-3383.
69. Wang Q, Doerschuk CM. The p38 mitogen-activated protein kinase mediates cytoskeletal remodeling in pulmonary microvascular endothelial cells upon intracellular adhesion molecule-1 ligation. J Immunol. 2001;166(11):6877-6884.
70. Adamson P, Etienne S, Couraud PO, et al. Lymphocyte migra-tion through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway J Immunol. 1999;162(5):2964-2973.
71. Etienne S, Adamson P, Greenwood J, et al. ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol. 1998;161(10):5755-5761.
72. Barreiro O, Yanez-Mo M, Serrador JM, et al. Dynamic inter-action of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol. 2002;157(7):1233-1245.
73. Carpen O, Pallai P, Staunton DE, Springer TA. Association of intercellular adhesion molecule-1 (ICAM-1) with actin-containing cytoskeleton and alpha-actinin. J Cell Biol. 1992; 118(5):1223-1234.
74. Federici C, Camoin L, Hattab M, et al. Association of the cytoplasmic domain of intercellular-adhesion molecule-1 with glyceraldehyde-3-phosphate dehydrogenase and beta-tubulin. EurJBiochem. 1996;238(1):173-180.
75. Henninger DD, Panes J, Eppihimer M, et al. Cytokine-induced VCAM-1 and ICAM-1 expression in different organs of the mouse. J Immunol. 1997;158(4):1825-1832.
76. Schwartz BR, Wayner EA, Carlos TM, et al. Identification of surface proteins mediating adherence ofCD11/CD18-deficient lymphoblastoid cells to cultured human endothelium. J Clin Invest. 1990;85(6):2019-2022.
77. Rothlein R, WegnerC. Role of intercellular adhesion molecule-1 in the inflammatory response. Kidney Int. 1992;41(3):617-619.
78. Albelda SM. Endothelial and epithelial cell adhesion molecules. Am JRespir Cell Mol Biol. 1991;4(3):195-203.
79. Springer TA. The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Annu Rev Cell Biol. 1990;6:359-402.
80. Perry VH, Anthony DC, Bolton SJ, Brown HC. The blood-brain barrier and the inflammatory response. Mol Med Today. 1997; 3(8):335-341.
81. Sobel RA, Mitchell ME, Fondren G. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am JPathol. 1990;136(6):1309-1316.
82. Sampietro T, Tuoni M, Ferdeghini M, et al. Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia. Circulation. 1997;96(5):1381-1385.
83. Yang PY, Rui YC. Intercellular adhesion molecule-1 and vascular endothelial growth factor expression kinetics in macrophage-derived foam cells. Life Sci. 2003;74(4):471-480.
84. Kowalska I, Straczkowski M, Szelachowska M, et al. Circulating E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism. Metabolism. 2002;51(6):733-736.
85. Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production. Atherosclerosis. 2005;183(2):259-267.
86. Bornemann A, Anderson LV. Diagnostic protein expression in human muscle biopsies. Brain Pathol. 2000;10(2):193-214.
87. Suzuki Y, Tanigaki T, Heimer D, et al. TGF-beta 1 causes increased endothelial ICAM-1 expression and lung injury. J Appl Physiol. 1994;77(3):1281-1287.
88. Muller AM, Hermanns MI, Cronen C, Kirkpatrick CJ. Compar-ative study of adhesion molecule expression in cultured human macro-and microvascular endothelial cells. Exp Mol Pathol. 2002;73(3):171-180.
89. Lee KH, Lawley TJ, Xu YL, Swerlick RA. VCAM-1-, ELAM-1-, and ICAM-1-independent adhesion of melanoma cells to cultured human dermal microvascular endothelial cells. J Invest Dermatol. 1992;98(1):79-85.
90. Weber C, Negrescu E, Erl W, et al. Inhibitors ofprotein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. J Immunol. 1995;155(1):445-451.
91. Ando J, Kamiya A. Blood flow and vascular endothelial cell function. Front Med Biol Eng. 1993;5(4):245-264.
92. Malek AM, Gibbons GH, Dzau VJ, Izumo S. Fluid shear stress differentially modulates expression of genes encoding basic fibroblast growth factor and platelet-derived growth factor B chain in vascular endothelium. J Clin Invest. 1993;92(4): 2013-2021.
93. Ballermann BJ, Dardik A, Eng E, Liu A. Shear stress and the endothelium. Kidney Int Suppl. 1998;67:S100-S108.
94. Chiu JJ, Lee PL, Chen CN, et al. Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-[alpha] in endothelial cells. Arterioscler Thromb VascBiol. 2004;24(1):73-79.
95. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995;75(3):519-560.
96. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Character-ization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). JBiol Chem. 1992;267(23):16323-16329.
97. Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. Induction by cytokines and phorbol ester. J Immunol. 1991;147(8):2777-2786.
98. Minami T, Aird WC. Thrombin stimulation of the vascular cell adhesion molecule-1 promoter in endothelial cells is mediated by tandem nuclear factor-kappa B and GATA motifs. J Biol Chem. 2001;276(50):47632-47641.
99. Moy P, Lobb R, Tizard R, et al. Cloning of an inflammation-specific phosphatidyl inositol-linked form of murine vascular cell adhesion molecule-1. J Biol Chem. 1993;268(12):8835-8841.
100. King PD, Sandberg ET, Selvakumar A, et al. Novel isoforms of murine intercellular adhesion molecule-1 generated by alterna-tive RNA splicing. J Immunol. 1995;154(11):6080-6093.
101. Giorelli M, De Blasi A, Defazio G, et al. Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a. Cell Commun Adhes. 2002;9(5-6):259-272.
102. Miller J, Knorr R, Ferrone M, et al. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J Exp Med. 1995;182(5):1231-1241.
103. Reilly PL, Woska JR Jr., Jeanfavre DD, et al. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. J Immunol. 1995;155(2):529-532.
104. Jun CD, Shimaoka M, Carman CV, et al. Dimerization and the effectiveness of ICAM-1 in mediating LFA-1-dependent adhe-sion. Proc Natl Acad Sci USA. 2001;98(12):6830-6835.
105. Garton KJ, Gough PJ, Philalay J, et al. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem. 2003;278(39):37459-37464.
106. Ricard I, Payet MD, Dupuis G. VCAM-1 is internalized by a clathrin-related pathway in human endothelial cells but its alpha beta 1 integrin counter-receptor remains associated with the plasma membrane in human T lymphocytes. Eur J Immunol. 1998;28(5):1708-1718.
107. Melis M, Pace E, Siena L, et al. Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space. Am J Respir Crit Care Med. 2003; 167(8):1131-1138.
108. Robledo O, Papaioannou A, Ochietti B, et al. ICAM-1 isoforms: specific activity and sensitivity to cleavage by leukocyte elastase and cathepsin G. Eur J Immunol. 2003;33(5):1351-1360.
109. Muro S, Gajewski C, Koval M, Muzykantov VR. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. Blood. 2005;105(2):650-658.
110. Muro S, Wiewrodt R, Thomas A, et al. A novel endocytic path-way induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci. 2003;116(Pt 8):1599-1609.
111. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogene-sis. Science. 1991;251(4995):788-791.
112. Poston RN, Haskard DO, Coucher JR, et al. Expression of inter-cellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol. 1992;140(3):665-673.
113. Iiyama K, Hajra L, Iiyama M, et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. CircRes. 1999;85(2):199-207.
114. Taichman DB, Cybulsky MI, Djaffar I, et al. Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1. Cell Regul. 1991; 2(5):347-355.
115. Xu H, Gonzalo JA, St Pierre Y, et al. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med. 1994;180(1):95-109.
116. Friedrich C, Cybulsky MI, Gutierrez-Ramos JC. Vascular cell adhesion molecule-1 expression by hematopoiesis-supporting stromal cells is not essential for lymphoid or myeloid differenti-ation in vivo or in vitro. Eur J Immunol. 1996;26(11):2773-2780.
117. Schleimer RP, Bochner BS. The role of adhesion molecules in allergic inflammation and their suitability as targets of antial-lergic therapy. Clin Exp Allergy. 1998;28(Suppl 3):15-23.
118. Bullard DC, Qin L, Lorenzo I, et al. P-selectin/ICAM-1 double mutant mice: acute emigration of neutrophils into the peri-toneum is completely absent but is normal into pulmonary alveoli. J Clin Invest. 1995;95(4):1782-1788.
119. Sligh JE Jr., Ballantyne CM, Rich SS, et al. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA. 1993; 90(18):8529-8533.
120. Gurtner GC, Davis V, Li H, et al. Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallan-toic fusion and placentation. Genes Dev. 1995;9(1):1-14.
121. Gonzalo JA, Lloyd CM, Kremer L, et al. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J Clin Invest. 1996;98(10):2332-2345.
122. Baron JL, Madri JA, Ruddle NH, et al. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med. 1993;177(1):57-68.
123. Muzykantov VR. Targeting Pulmonary Endothelium. Boston: Kluwer Academic Publishers, 2002.
124. Kumasaka T, Quinlan WM, Doyle NA, et al. Role of the inter-cellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. J Clin Invest. 1996;97(10):2362-2369.
125. Rothlein R, Mainolfi EA, Kishimoto TK. Treatment of inflam-mation with anti-ICAM-1. Res Immunol. 1993;144(9):735-739; discussion 54-62.
126. Sakhalkar HS, Dalal MK, Salem AK, et al. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo. Proc Natl Acad Sci USA. 2003;100(26):15895-15900.
127. Tsourkas A, Shinde-Patil VR, Kelly K, et al. In vivo imaging of activated endothelium using an anti-VCAM-1 magneto-optical probe. Bioconjug Chem. 2005;16(3):576-581.
128. Kelly K, Allport JR, Tsourkas A, et al. Detection ofvascular adhesion molecule-1 expression using a novel multimodal nanoparticle. CircRes. 2005;96(3):327-336.
129. Murciano JC, Muro S, Koniaris L, et al. ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface. Blood. 2003;101(10):3977-3984.
130. Wiewrodt R, Thomas AP, Cipelletti L, et al. Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells. Blood. 2002;99(3):912-922.
131. Atochina EN, Balyasnikova IV, Danilov SM, et al. Immunotar-geting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. Am J Physiol. 1998;275(4 Pt 1):L806-L817.
132. Christofidou-Solomidou M, Scherpereel A, Wiewrodt R, et al. PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress. Am J Physiol Lung Cell Mol Physiol. 2003;285(2):L283-L292.
133. Kozower BD, Christofidou-Solomidou M, Sweitzer TD, et al. Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. NatBiotechnol. 2003;21(4):392-398.
134. Muro S, Cui X, Gajewski C, et al. Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress. Am J Physiol Cell Physiol. 2003;285(5):C1339-C1347.
135. Scherpereel A, Rome JJ, Wiewrodt R, et al. Platelet-EC adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature. J Pharmacol Exp Ther. 2002;300(3):777-786.
136. Muro S, Mateescu M, Gajewski G, et al. Control of intracellular trafficking of ICAM-1-targeted nanocarriers by endothelial Na+/H+ exchanger (NHE) proteins. Am J Physiol Lung Cell Mol Physiol. 2006;290(5):L809-817.
137. Muro S, Koval M, Muzykantov V. Endothelial endocytic pathways: gates for vascular drug delivery. Curr VascPharmacol. 2004;2(3):281-299.
138. Muro S, Schuchman EH, Muzykantov VR. Lysosomal enzyme delivery by ICAM-1-targeted nanocarriers bypassing glycosylation-and clathrin-dependent endocytosis. Mol Ther. 2006 Jan;13(1):135-141.
139. Schuchman EH, Muro S. The development of enzyme replace-ment therapy for lysosomal diseases: Gaucher disease and beyond. In: Futerman AH, ed. Gaucher Disease: Lessons Learned about Therapy of Lysosomal Disorders. Boca Raton: CRC Press, 2006.